Sinclair Pharma (LSE:SPH)
Historical Stock Chart

From Apr 2019 to Apr 2024

TIDMSPH

RNS Number : 3989D

Sinclair Pharma PLC

26 April 2017

Sinclair Pharma plc

Result of AGM

London, 26 April 2017 Sinclair Pharma plc (SPH.L), ("Sinclair") the international Aesthetics company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information please contact:

 
 Sinclair Pharma plc   Tel: +44 (0) 20 7467 
                        6920 
 Chris Spooner 
  Alan Olby 
  Andy Crane 
 
 
 Peel Hunt LLP (NOMAD and   Tel: +44 (0) 20 7418 
  Joint Broker)              8900 
 James Steel 
  Oliver Jackson 
 
 
 RBC Capital Markets (Joint   Tel: +44 (0) 20 7653 
  Broker)                      4000 
 Marcus Jackson 
  Laura White 
 

Media enquiries

 
 FTI Consulting        Tel: +44 (0) 203 727 
                        1000 
 Ben Atwell 
  Brett Pollard 
  Stephanie Cuthbert 
 

Notes to Editors:

About Sinclair Pharma plc

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors.

For more information, please visit

www.sinclairpharma.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGOKADQCBKKCQB

(END) Dow Jones Newswires

April 26, 2017 05:50 ET (09:50 GMT)